CooleyREG

Applicable to all industries, this session will cover how government leadership transitions affect business. The session will highlight critical elements of transition periods, including anticipated regulatory shifts and strategies to manage uncertainty. Updates from key government agencies – including the Federal Trade Commission (FTC), Department of Justice (DOJ) and Federal Communications Commission (FCC) – will be discussed. The session also will provide an overview of the Congressional Review Act’s power to jettison a prior administration’s regulations through a majority vote and potential areas of congressional investigation.

This session will explore how new leadership and evolving policy priorities will affect the technology industry. It will analyze expected changes in areas such as antitrust enforcement, data privacy, content moderation, congressional investigations and regulatory frameworks for next-generation technologies like artificial intelligence. Gain insights into how your business can adapt to stay ahead of compliance challenges and capitalize on new opportunities.

With the new administration ushering in potential shifts in healthcare policy and regulatory oversight, this session will focus on anticipated changes for the life sciences industry, including potential enforcement discretion policies that could impact existing rules and enforcement priorities at the Food and Drug Administration (FDA), Federal Trade Commission (FTC) and other federal agencies. Learn how to strategically position your business amid an evolving regulatory landscape.

Join members of our financial services and government analytics teams to hear their predictions of what’s in and what’s out with the new administration and the implications for financial institutions, banks and fintechs. Topics will include the latest updates from the Hill on areas of potential congressional interest, resolution of new rulemakings in the Congressional Review Act window, and what to expect from (and for) the Consumer Financial Protection Bureau, Federal Trade Commission, Department of Justice and state attorneys general.

Brussels clearances have weighed heavy on past deal timelines and deal certainty. What are the potential future pitfalls and paths to successful closing?

Our first session will cover topics such as merger review, foreign subsidies review, foreign direct investment, technology and artificial intelligence (AI) regulation, environmental, social and governance (ESG), secure supply chains and the European Green Deal.

What initiatives are geared to drive tech innovation and accelerate routes to market in the EU? This session will cover topics such as data regulation and competition enforcement, data and consumer protection, ESG, secure supply chains, cyber resilience, connected devices, and cloud and AI regulation.

What initiatives are geared to drive biotech and medtech innovation and to accelerate routes to market in the EU? This session will cover topics such as pharma and medtech regulation, medical product initiatives, preventive health initiatives, life sciences and data, and competition law enforcement.